{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:02:39Z","timestamp":1791226959816,"version":"4.1.0"},"reference-count":69,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,7,1]]},"DOI":"10.1210\/mend.12.7.0136","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:30:02Z","timestamp":1389202202000},"page":"941-953","source":"Crossref","is-referenced-by-count":158,"title":["Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest"],"prefix":"10.1210","volume":"12","author":[{"given":"John M.","family":"Kokontis","sequence":"first","affiliation":[{"name":"The Ben May Institute for Cancer Research (J.M.K., N.H., S.L.), Illinois 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissim","family":"Hay","sequence":"additional","affiliation":[{"name":"The Ben May Institute for Cancer Research (J.M.K., N.H., S.L.), Illinois 60637"},{"name":"The Departments of Pharmacology and Physiology (N.H.), Illinois 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutsung","family":"Liao","sequence":"additional","affiliation":[{"name":"The Ben May Institute for Cancer Research (J.M.K., N.H., S.L.), Illinois 60637"},{"name":"Biochemistry and Molecular Biology (S.L.) The University of Chicago Chicago, Illinois 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041201433535200_R1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland.","volume":"43","author":"Huggins","year":"1941","journal-title":"Arch Surg"},{"key":"2019041201433535200_R2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJM199410133311507","article-title":"Management of cancer of the prostate.","volume":"331","author":"Catalona","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041201433535200_R3","first-page":"419","article-title":"A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. (published erratum appears in","volume":"321","author":"Crawford","year":"1989","journal-title":"N Engl J Med 1989, 321:1420) N Engl J Med"},{"key":"2019041201433535200_R4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pros.2990090306","article-title":"Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.","volume":"9","author":"Isaacs","year":"1986","journal-title":"Prostate"},{"key":"2019041201433535200_R5","first-page":"2275","article-title":"Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.","volume":"50","author":"Bruchovsky","year":"1990","journal-title":"Cancer Res"},{"key":"2019041201433535200_R6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1349-7006.1993.tb02838.x","article-title":"Progression of androgen-sensitive mouse tumor (Shionogi carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone.","volume":"84","author":"Sato","year":"1993","journal-title":"Jpn J Cancer Res"},{"key":"2019041201433535200_R7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0960-0760(95)00117-I","article-title":"Molecular mechanism of androgen-dependent growth in transformed cells. Pathway from basic science to clinical application.","volume":"54","author":"Koga","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0960-0760(95)00001-G","article-title":"Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer.","volume":"52","author":"Baley","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R9","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma.","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res"},{"key":"2019041201433535200_R10","first-page":"1566","article-title":"Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.","volume":"54","author":"Kokontis","year":"1994","journal-title":"Cancer Res"},{"key":"2019041201433535200_R11","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1073\/pnas.93.21.11802","article-title":"Human prostate tumor growth in athymic mice: inhibition by androgens and stimuation by a 5\u03b1-reductase inhibitor.","volume":"93","author":"Umekita","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201433535200_R12","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer Res"},{"key":"2019041201433535200_R13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.2910570319","article-title":"Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.","volume":"57","author":"Wu","year":"1994","journal-title":"Int J Cancer"},{"key":"2019041201433535200_R14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0960-0760(96)00018-0","article-title":"Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.","volume":"58","author":"Sato","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/bjc.1997.32","article-title":"Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.","volume":"75","author":"Hyytinen","year":"1997","journal-title":"Br J Cancer"},{"key":"2019041201433535200_R16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pros.2990070208","article-title":"Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r.","volume":"7","author":"Hasenson","year":"1985","journal-title":"Prostate"},{"key":"2019041201433535200_R17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00262024","article-title":"The human prostatic carcinoma cell line LNCaP and its derivatives.","volume":"17","author":"van Steenbrugge","year":"1989","journal-title":"Urol Res"},{"key":"2019041201433535200_R18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0960-0760(91)90184-7","article-title":"The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.","volume":"40","author":"van Steenbrugge","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pros.2990230304","article-title":"Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP.","volume":"23","author":"Langeler","year":"1993","journal-title":"Prostate"},{"key":"2019041201433535200_R20","first-page":"545","article-title":"Variants of the human prostate LNCaP carcinoma cell line as tools to study discrete components of the androgen-mediated proliferative response.","volume":"7","author":"Soto","year":"1995","journal-title":"Oncol Res"},{"key":"2019041201433535200_R21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","article-title":"Inhibitors of mammalian G1 cyclin-dependent kinases.","volume":"9","author":"Sherr","year":"1995","journal-title":"Genes Dev"},{"key":"2019041201433535200_R22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control.","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"2019041201433535200_R23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","article-title":"A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.","volume":"173","author":"Veldscholte","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041201433535200_R24","first-page":"271","article-title":"Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells: altered hormone and antihormone specificity in gene transactivation.","volume":"1","author":"Kokontis","year":"1991","journal-title":"Receptor"},{"key":"2019041201433535200_R25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1210\/endo-126-3-1457","article-title":"The proliferative effect of \u201canti-androgens\u201d on the androgen-sensitive human prostate tumor cell line LNCAP.","volume":"126","author":"Olea","year":"1990","journal-title":"Endocrinology"},{"key":"2019041201433535200_R26","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/bi00123a026","article-title":"Anti-androgens and the mutated androgen receptor of the LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation.","volume":"31","author":"Veldscholte","year":"1992","journal-title":"Biochemistry"},{"key":"2019041201433535200_R27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0021-9258(18)48380-9","article-title":"Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation.","volume":"267","author":"Kemppainen","year":"1992","journal-title":"J Biol Chem"},{"key":"2019041201433535200_R28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/mend-4-1-22","article-title":"Autologous down-regulation of androgen receptor messenger ribonucleic acid.","volume":"4","author":"Quarmby","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2019041201433535200_R29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0303-7207(91)90262-Q","article-title":"Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells.","volume":"76","author":"Krongrad","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"2019041201433535200_R30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/mend.11.2.9883","article-title":"An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.","volume":"11","author":"Cleutjens","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041201433535200_R31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/nar\/20.7.1785","article-title":"Modifications of the E. coli Lac repressor for expression in eukaryotic cells: effects of nuclear signal sequences on protein activity and nuclear accumulation.","volume":"20","author":"Fieck","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"2019041201433535200_R32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-1119(96)00532-X","article-title":"Inducible retroviral vectors regulated by lac repressor in mammalian cells.","volume":"183","author":"Chang","year":"1996","journal-title":"Gene"},{"key":"2019041201433535200_R33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","article-title":"Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.","volume":"269","author":"Pagano","year":"1995","journal-title":"Science"},{"key":"2019041201433535200_R34","first-page":"5070","article-title":"Adaptation vs. selection as the mechanism responsible for the relapse of prostate cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.","volume":"41","author":"Isaacs","year":"1981","journal-title":"Cancer Res"},{"key":"2019041201433535200_R35","first-page":"2918","article-title":"Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.","volume":"80","author":"Masamura","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041201433535200_R36","first-page":"3068","article-title":"Distant metastases from prostatic carcinoma express androgen receptor protein.","volume":"55","author":"Hobisch","year":"1995","journal-title":"Cancer Res"},{"key":"2019041201433535200_R37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.2910480206","article-title":"Androgen receptors in endocrine-therapy-resistant human prostate cancer.","volume":"48","author":"van der Kwast","year":"1991","journal-title":"Int J Cancer"},{"key":"2019041201433535200_R38","first-page":"735","article-title":"Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.","volume":"144","author":"Ruizeveld de Winter","year":"1994","journal-title":"Am J Pathol"},{"key":"2019041201433535200_R39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer.","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat Genet"},{"key":"2019041201433535200_R40","first-page":"314","article-title":"Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.","volume":"57","author":"Koivisto","year":"1997","journal-title":"Cancer Res"},{"key":"2019041201433535200_R41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(87)90121-8","article-title":"Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors.","volume":"51","author":"Darbre","year":"1987","journal-title":"Cell"},{"key":"2019041201433535200_R42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0960-0760(92)90446-P","article-title":"Loss of androgen dependency with preservation of functional androgen receptors in androgen-dependent mouse tumour (Shionogi carcinoma 115).","volume":"42","author":"Furuya","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R43","first-page":"5474","article-title":"Androgen receptor activation in prostate tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.","volume":"54","author":"Culig","year":"1994","journal-title":"Cancer Res"},{"key":"2019041201433535200_R44","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1210\/endo.137.10.8828495","article-title":"Effects of mitogens on androgen receptor-mediated transactivation.","volume":"137","author":"Reinikainen","year":"1996","journal-title":"Endocrinology"},{"key":"2019041201433535200_R45","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.1074\/jbc.271.33.19900","article-title":"Activation of the human androgen receptor through a protein kinase A signaling pathway.","volume":"271","author":"Nazareth","year":"1996","journal-title":"J Biol Chem"},{"key":"2019041201433535200_R46","first-page":"1598","article-title":"Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.","volume":"52","author":"Gleave","year":"1992","journal-title":"Cancer Res"},{"key":"2019041201433535200_R47","doi-asserted-by":"crossref","first-page":"15152","DOI":"10.1073\/pnas.93.26.15152","article-title":"Androgen-repressed phenotype in human prostate cancer.","volume":"93","author":"Zhau","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201433535200_R48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/bjc.1991.237","article-title":"Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.","volume":"64","author":"Wolf","year":"1991","journal-title":"Br J Cancer"},{"key":"2019041201433535200_R49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0960-0760(94)90022-1","article-title":"Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.","volume":"50","author":"Smith","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0960-0760(95)00155-S","article-title":"Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.","volume":"55","author":"Joly-Pharaboz","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041201433535200_R51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1210\/endo.137.3.8603613","article-title":"Transforming growth factor-\u03b21 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.","volume":"137","author":"Kim","year":"1996","journal-title":"Endocrinology"},{"key":"2019041201433535200_R52","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1210\/endo.138.8.5328","article-title":"1\u03b1,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.","volume":"138","author":"Zhao","year":"1997","journal-title":"Endocrinology"},{"key":"2019041201433535200_R53","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","article-title":"Biphasic regulation of breast cancer cell growth by progesterone: role of cyclin-dependent kinase inhibitors, p21 and p27Kip1.","volume":"11","author":"Groshong","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041201433535200_R54","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1006\/bbrc.1996.1546","article-title":"Proteasome-dependent regulation of p21WAF1\/CIP1 expression.","volume":"227","author":"Blagosklonny","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041201433535200_R55","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","article-title":"Translational control of p27Kip1 accumulation during the cell cycle.","volume":"271","author":"Hengst","year":"1996","journal-title":"Science"},{"key":"2019041201433535200_R56","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1074\/jbc.272.11.7093","article-title":"Enhanced ribosomal association of p27Kip1 mRNA is a mechanism contributing to accumulation during growth arrest.","volume":"272","author":"Millard","year":"1997","journal-title":"J Biol Chem"},{"key":"2019041201433535200_R57","first-page":"3666","article-title":"Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145.","volume":"56","author":"Peng","year":"1996","journal-title":"Cancer Res"},{"key":"2019041201433535200_R58","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1002\/j.1460-2075.1996.tb01050.x","article-title":"Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.","volume":"15","author":"Vlach","year":"1996","journal-title":"EMBO J"},{"key":"2019041201433535200_R59","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1002\/j.1460-2075.1995.tb00163.x","article-title":"Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.","volume":"14","author":"Steiner","year":"1995","journal-title":"EMBO J"},{"key":"2019041201433535200_R60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/387422a0","article-title":"Myc and Ras collaborate in inducing accumulation of active cyclin E\/Cdk2 and E2F.","volume":"387","author":"Leone","year":"1997","journal-title":"Nature"},{"key":"2019041201433535200_R61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/bjc.1992.76","article-title":"Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone.","volume":"65","author":"Wolf","year":"1992","journal-title":"Br J Cancer"},{"key":"2019041201433535200_R62","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z","article-title":"Effects of intermittent androgen suppression on androgen-dependent tumors.","volume":"71","author":"Akakura","year":"1993","journal-title":"Cancer"},{"key":"2019041201433535200_R63","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0090-4295(99)80092-2","article-title":"Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.","volume":"45","author":"Goldenberg","year":"1995","journal-title":"Urology"},{"key":"2019041201433535200_R64","first-page":"4511","article-title":"Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.","volume":"57","author":"Lu","year":"1997","journal-title":"Cancer Res"},{"key":"2019041201433535200_R65","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(17)38062-6","article-title":"Estrogen control of progesterone receptor in human breast cancer.","volume":"253","author":"Horwitz","year":"1978","journal-title":"J Biol Chem"},{"key":"2019041201433535200_R66","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression.","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell"},{"key":"2019041201433535200_R67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","article-title":"Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitotic signals.","volume":"78","author":"Polyak","year":"1994","journal-title":"Cell"},{"key":"2019041201433535200_R68","first-page":"5616","article-title":"Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers.","volume":"47","author":"Tokunaga","year":"1987","journal-title":"Cancer Res"},{"key":"2019041201433535200_R69","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/12\/7\/941\/8955070\/mend0941.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:23:08Z","timestamp":1647908588000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/12\/7\/941\/2754436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7,1]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/mend.12.7.0136","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7,1]]}}}